SALOUA BOUTALEB SLIMANI – Trademark Portfolio

Entity Type: 01

SALOUA BOUTALEB SLIMANI holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AKASHINE. The owner is based in MONTREAL.

5109 boulevard Lasalle

MONTREAL H4G2C1 , CA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SALOUA BOUTALEB SLIMANI's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SALOUA BOUTALEB SLIMANI have?

SALOUA BOUTALEB SLIMANI has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does SALOUA BOUTALEB SLIMANI file in?

SALOUA BOUTALEB SLIMANI files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are SALOUA BOUTALEB SLIMANI's most well-known trademarks?

SALOUA BOUTALEB SLIMANI's registered trademark portfolio includes well-known marks such as AKASHINE. These are among 1 currently registered trademark in the portfolio.

What is SALOUA BOUTALEB SLIMANI's trademark registration success rate?

SALOUA BOUTALEB SLIMANI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.